SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Viyash Scientific Ltd

BSE: 512529 NSE: VIYASH ISIN: INE807F01027
  |   Sector:  Healthcare   |   Industry:  Pharmaceuticals & Drugs

Snapshot

Q.1 Which industry/sub-sector does Viyash Scientific Ltd belong to?
Viyash Scientific Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.2 Is Viyash Scientific Ltd a good quality company?
Viyash Scientific Ltd is a average quality company, based on a somewhat consistent 10 year financial track record.
Q.3 Is Viyash Scientific Ltd undervalued or overvalued?
Viyash Scientific Ltd appears Somewhat overvalued, as its key valuation ratios are above with their past averages.
Q.4 Is Viyash Scientific Ltd a good buy now?
Viyash Scientific Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Viyash Scientific Ltd?
Viyash Scientific Ltd revenue growth is 13.3% for FY-2025 , which is above its 5 year CAGR of 5.6% , indicating faster growth.
Q.2 Gross Profit margin of Viyash Scientific Ltd?
Viyash Scientific Ltd Gross profit margin which is the profit after deduction of direct costs, is 7.2% for FY-2025 , which is in line with its 5 year median of 7.2% , indicating stable margins.
Q.3 Operating Profit Margin of Viyash Scientific Ltd?
Viyash Scientific Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 10.76% for FY-2025 , which is above its 5 year median of 7.75% indicating increasing margins.
Q.4 Net Profit Margin of Viyash Scientific Ltd?
Viyash Scientific Ltd Net Profit Margin is 2.08% for FY-2025 , is in line with with its 5 year median of 2.08%, indicating stable margins.
Current Level Historic Median
Gross Profit Margin 7.2 7.2
Operating Profit Margin 10.76 7.75
Net Profit Margin 2.08 2.08
Q.5 Return on Asset of Viyash Scientific Ltd?
Viyash Scientific Ltd Return on Asset is 2.08%, which is in line with its 5 year historical median of 2.08%, indicating stable asset utilization efficiency.
Q.6 Return on Equity (ROE) of Viyash Scientific Ltd?
Viyash Scientific Ltd Return on equity is 5.44% for FY-2025 , which is in line with its historical median of 5.44%, indicating the business is making similar use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Viyash Scientific Ltd?
Viyash Scientific Ltd Return on capital employed is 9.3% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8 Cash conversion cycle of Viyash Scientific Ltd?
Viyash Scientific Ltd Cash conversion cycle is 95 days, above its historical median of 95 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 1.03 0.98
ROE 5.44 5.44
ROCE 9.3 7.01
Cash Conversion Cycle 95 days 95 days
Q.9 Debt to Equity ratio of Viyash Scientific Ltd?
Viyash Scientific Ltd Debt-to-Equity ratio is 0.73 , which is above with the industry average of 0.15 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Viyash Scientific Ltd?
Viyash Scientific Ltd Debt to cash flow from operations is 5.35 , which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Viyash Scientific Ltd?
Promoters hold 61.41% of the Viyash Scientific Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Viyash Scientific Ltd vs industry peers?
Viyash Scientific Ltd revenue CAGR is 5.64% , compared to the industry median CAGR of 5.54% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 1,551.4 137.1
Gross Profit 111.7 15.1
Operating Profit 159 16
Net Profit 32 5.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 1.03 0.8
ROE 5.44 8.91
ROCE 9.3 11.59
Cash Conversion Cycle (days) 94.53 76

Valuation & price assessment

Q.1 Stock return of Viyash Scientific Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 2.4% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 2.4% -4.1% 43.6% 41.5%
Q.3 Valuation ratios of Viyash Scientific Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 118.79 44.94 40.28
Price to Book 10.14 4.79 2.77
Price to Sales 4.29 2.79 2.65
EV to EBITDA 27.06 19.20 15.67

Check more companies

1. Ajanta Pharma
2. JB Chem & Pharma
3. Emcure Pharma
4. Gland Pharma
5. Wockhardt
6. Pfizer
7. Astrazeneca Pharma I
8. Sai Life Sciences
9. Natco Pharma
10. Eris Lifesciences
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×